Age-dependent Accumulation of Soluble Amyloid β (Aβ) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-α (sAPPα) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3β Pathway in Alzheimer Mouse Model
Open Access
- 1 May 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (21), 18414-18425
- https://doi.org/10.1074/jbc.m110.209718
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's diseaseNeurobiology of Disease, 2010
- Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegenerationProceedings of the National Academy of Sciences, 2010
- The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic DystrophyIn VitroandIn VivoJournal of Neuroscience, 2009
- Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric AβJournal of Biological Chemistry, 2009
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic MiceThe American Journal of Pathology, 2008
- Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomersNeurobiology of Aging, 2007
- Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotectionNeurobiology of Disease, 2007
- The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathwaysProgress in Neurobiology, 2006
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003